Home / Research / Manufacturers / Diagnostica Stago, Inc. Medical-device intelligence
Diagnostica Stago, Inc.: FDA clearances and recalls Research Diagnostica Stago, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 17 clearance records and 42 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Feb 12, 2001 to Sep 24, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 1 January 2026 0 0 February 2026 0 2 March 2026 0 0 April 2026 1 0 May 2026 0 0 June 2026 0 0 July 2026 0 1 August 2026 0 0 September 2026 1 0 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls JPA · System, Multipurpose For In Vitro Coagulation Studies 4 6 GJS · Test, Time, Prothrombin 0 9 GGP · Test, Qualitative And Quantitative Factor Deficiency 2 6 GGN · Plasma, Coagulation Control 3 2 KFF · Assay, Heparin 2 3 GFO · Activated Partial Thromboplastin 1 3 DAP · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control 0 3 GKP · Instrument, Coagulation, Automated 0 3 LCO · Platelet Factor 4 Radioimmunoassay 1 1 GGC · Control, Plasma, Abnormal 1 0 GGW · Test, Time, Partial Thromboplastin 0 1 GIR · Reagent, Russel Viper Venom 1 0
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 59 matching records Device / record Company in FDA record Source Source date STA® - Liquid Anti-Xa K260214 · KFFDiagnostica Stago, Inc. 510(k) Sep 24, 2026FDA decision date STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074;
qualitative and quantitative factor deficiency test Z-3047-2026 · GGPDiagnostica Stago, Inc. Recall Aug 28, 2026FDA classification date STA Satellite Max® K253658 · JPADiagnostica Stago, Inc. 510(k) Apr 27, 2026FDA decision date Brand Name: STA Liatest D-Di
Product Name: STA Liatest D-Di
Model/Catalog Number: REF 00515
Product Description: in vitro diagnostic. The STA … Z-1585-2026 · DAPDiagnostica Stago, Inc. Recall Mar 19, 2026FDA classification date Brand Name: STA Liatest Free Protein S
Product Name: STA Liatest Free Protein S
Model/Catalog Number (REF): 00516
Product Description: The STA - … Z-1491-2026 · GGPDiagnostica Stago, Inc. Recall Mar 3, 2026FDA classification date Asserachrom HPIA.
Model/Catalog Number: 00615.
The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the ant… Z-1084-2026 · LCODiagnostica Stago, Inc. Recall Jan 14, 2026FDA classification date Product: STA Liatest D-Di;
REF: 00515; Z-0205-2026 · DAPDiagnostica Stago, Inc. Recall Oct 16, 2025FDA classification date STA Satellite. Product Code: All references. All software versions.
The STA Satellite is a fully automated benchtop analyzer capable of simultan… Z-2473-2025 · JPADiagnostica Stago, Inc. Recall Aug 28, 2025FDA classification date STA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US.
The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellit… Z-2474-2025 · KFFDiagnostica Stago, Inc. Recall Aug 28, 2025FDA classification date STA-Liquid Anti-Xa 8. Model/Catalog Number: 00322US.
The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satelli… Z-2475-2025 · KFFDiagnostica Stago, Inc. Recall Aug 28, 2025FDA classification date STA - Fibrinogen 5. Model/Catalog Number: 00674.
The STA - Fibrinogen 5 kit is intended for use with the analyzers of the STA-R, STA Compact an… Z-2476-2025 · KQJDiagnostica Stago, Inc. Recall Aug 28, 2025FDA classification date STA - Owren Koller. Model/Catalog Number: 00360
STA - Owren-Koller is a buffer solution intended for use as a diluent for reagents and human pla… Z-1993-2025 · PPMDiagnostica Stago, Inc. Recall Jun 18, 2025FDA classification date STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59026 Z-1575-2023 · JPADiagnostica Stago, Inc. Recall May 10, 2023FDA classification date STA Compact Automated Multi-Parametric Analyzer, Reference Numbers 58602 and 58612 Z-1576-2023 · JPADiagnostica Stago, Inc. Recall May 10, 2023FDA classification date STA Compact Max fully automatic clinical analyzer, Reference Numbers 58602 and 58612 Z-1577-2023 · JPADiagnostica Stago, Inc. Recall May 10, 2023FDA classification date STA - Deficient VIII, Product Code: 00725.
STA - Deficient VIII is an immuno-depleted human plasma intended for use in tests for the determinatio… Z-1699-2020 · GGPDiagnostica Stago, Inc. Recall Apr 10, 2020FDA record creation date STA UNICALIBRATOR (ref. 00675) Z-0737-2020 · GIZDiagnostica Stago, Inc. Recall Dec 23, 2019FDA classification date STA SYSTEM CONROL N + P (ref. 00678) Z-0738-2020 · GGNDiagnostica Stago, Inc. Recall Dec 23, 2019FDA classification date Staclot LA (REF 00600)
The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagu… Z-0610-2019 · GFODiagnostica Stago, Inc. Recall Dec 14, 2018FDA record creation date Staclot LA 20 (REF 00594)
The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus antico… Z-0611-2019 · GFODiagnostica Stago, Inc. Recall Dec 14, 2018FDA record creation date Diagnostica Stago STA Noplastine CI Plus, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma.
(REF 00667)… Z-2993-2018 · GJSDiagnostica Stago, Inc. Recall Sep 7, 2018FDA record creation date Diagnostica Stago STA Noplastine CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma.
REF: 00666
The S… Z-2994-2018 · GJSDiagnostica Stago, Inc. Recall Sep 7, 2018FDA record creation date Neoplastine Cl Plus @ (ref.00374)
Product Usage:
Manual or automated determination of the prothrombin time (PT). Z-1066-2018 · GJSDiagnostica Stago, Inc. Recall Mar 15, 2018FDA record creation date Neoplastine Cl Plus (ref. 00375)
Product Usage:
Manual or automated determination of the prothrombin time (PT). Z-1067-2018 · GJSDiagnostica Stago, Inc. Recall Mar 15, 2018FDA record creation date STA - Neoplastine Cl (ref. 00605)
Product Usage:
Manual or automated determination of the prothrombin time (PT). Z-1068-2018 · GJSDiagnostica Stago, Inc. Recall Mar 15, 2018FDA record creation date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗